journal article·2024-06Open access

Lipid and Transcriptional Regulation in a Parkinson's Disease Mouse Model by Intranasal Vesicular and Hexosomal Plasmalogen‐Based Nanomedicines

Yu Wu, Jieli Wang, Yuru Deng, Borislav Angelov, Takehiko Fujino, Md. Shamim Hossain, Angelina Angelova

Advanced Healthcare Materials· Volume 13· Issue 14

Abstract

Abstract Plasmalogens (vinyl‐ether phospholipids) are an emergent class of lipid drugs against various diseases involving neuro‐inflammation, oxidative stress, mitochondrial dysfunction, and altered lipid metabolism. They can activate neurotrophic and neuroprotective signaling pathways but low bioavailabilities limit their efficiency in curing neurodegeneration. Here, liquid crystalline lipid nanoparticles (LNPs) are created for the protection and non‐invasive intranasal delivery of purified scallop‐derived plasmalogens. The in vivo results with a transgenic mouse Parkinson's disease (PD) model (characterized by motor impairments and α‐synuclein deposition) demonstrate the crucial importance of LNP composition, which determines the self‐assembled nanostructure type. Vesicle and hexosome nanostructures (characterized by small‐angle X‐ray scattering) display different efficacy of the nanomedicine‐mediated recovery of motor function, lipid balance, and transcriptional regulation (e.g., reduced neuro‐inflammation and PD pathogenic gene expression). Intranasal vesicular and hexosomal plasmalogen‐based LNP treatment leads to improvement of the behavioral PD symptoms and downregulation of the Il6, Il33, and Tnfa genes. Moreover, RNA‐sequencing and lipidomic analyses establish a dramatic effect of hexosomal nanomedicines on PD amelioration, lipid metabolism, and the type and number of responsive transcripts that may be implicated in neuroregeneration.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior · Supramolecular Self-Assembly in Materials · Polydiacetylene-based materials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Université Paris‐Saclay Institut Galien Paris‐Saclay CNRS 17 Av. des Sciences Orsay 91190 France

Wenzhou Institute University of Chinese Academy of Sciences No.1, Jinlian Road, Longwan District Wenzhou Zhejiang 325001 China

Department of Structural Dynamics Extreme Light Infrastructure ERIC Dolni Brezany CZ‐25241 Czech Republic

Institute of Rheological Functions of Food 2241‐1 Kubara, Hisayama‐cho Kasuya‐gun Fukuoka 811‐2501 Japan

Funding

Chinese Academy of Sciences

References (82)

Show source-provided references
1. 10.1007/s40291-023-00654-110.1007/s40291-023-00654-1 ↗
2. 10.3389/fnins.2020.0049410.3389/fnins.2020.00494 ↗
3. 10.1021/acsami.9b1604710.1021/acsami.9b16047 ↗
4. 10.3390/pharmaceutics1408173110.3390/pharmaceutics14081731 ↗
5. 10.3389/fbioe.2021.67259410.3389/fbioe.2021.672594 ↗
6. 10.1038/s41531-019-0103-710.1038/s41531-019-0103-7 ↗
7. 10.1016/S0140-6736(21)00218-X10.1016/S0140-6736(21)00218-X ↗
8. 10.1021/acs.molpharmaceut.1c0064810.1021/acs.molpharmaceut.1c00648 ↗
9. 10.1016/j.jconrel.2022.09.03910.1016/j.jconrel.2022.09.039 ↗
10. 10.1016/j.ijpharm.2021.12113110.1016/j.ijpharm.2021.121131 ↗
11. 10.1021/acsnano.1c0499610.1021/acsnano.1c04996 ↗
12. 10.1021/acsnano.3c0118610.1021/acsnano.3c01186 ↗
13. 10.1021/acsnano.2c0621310.1021/acsnano.2c06213 ↗
14. 10.1021/acsami.2c1437510.1021/acsami.2c14375 ↗
15. 10.1016/j.jconrel.2011.03.03310.1016/j.jconrel.2011.03.033 ↗
16. 10.3389/fcell.2021.67514010.3389/fcell.2021.675140 ↗
17. 10.1523/JNEUROSCI.2721-18.201910.1523/JNEUROSCI.2721-18.2019 ↗
18. 10.1016/j.jconrel.2016.11.02510.1016/j.jconrel.2016.11.025 ↗
19. 10.1016/j.ijpharm.2011.09.02210.1016/j.ijpharm.2011.09.022 ↗
20. 10.1016/j.jcis.2021.07.07010.1016/j.jcis.2021.07.070 ↗
21. 10.1016/j.ijpharm.2021.12088110.1016/j.ijpharm.2021.120881 ↗
22. 10.3389/fnins.2019.0032810.3389/fnins.2019.00328 ↗
23. 10.3390/cells801002710.3390/cells8010027 ↗
24. 10.1186/s10020-021-00279-210.1186/s10020-021-00279-2 ↗
25. 10.1007/s00415-020-10291-x10.1007/s00415-020-10291-x ↗
26. 10.2119/molmed.2011.0011910.2119/molmed.2011.00119 ↗
27. 10.3390/ijms2214763010.3390/ijms22147630 ↗
28. 10.3390/pharmaceutics1404083610.3390/pharmaceutics14040836 ↗
29. 10.1016/j.brainresbull.2022.08.00910.1016/j.brainresbull.2022.08.009 ↗
30. 10.1016/j.ebiom.2017.02.01210.1016/j.ebiom.2017.02.012 ↗
31. 10.1046/j.1471-4159.2001.00332.x10.1046/j.1471-4159.2001.00332.x ↗
32. 10.1016/j.nbd.2020.10506110.1016/j.nbd.2020.105061 ↗
33. 10.3390/antiox1102019210.3390/antiox11020192 ↗
34. 10.1016/j.brainres.2021.14751610.1016/j.brainres.2021.147516 ↗
35. 10.1039/D1FO03345J10.1039/D1FO03345J ↗
36. 10.1016/j.bbr.2015.03.01210.1016/j.bbr.2015.03.012 ↗
37. 10.1155/2020/267107010.1155/2020/2671070 ↗
38. 10.1038/s42004-023-01043-910.1038/s42004-023-01043-9 ↗
39. 10.1016/j.nbd.2004.07.00110.1016/j.nbd.2004.07.001 ↗
40. 10.3389/fnmol.2020.0008010.3389/fnmol.2020.00080 ↗
41. 10.1016/j.jchromb.2018.01.02510.1016/j.jchromb.2018.01.025 ↗
42. 10.1016/S0896-6273(02)00682-710.1016/S0896-6273(02)00682-7 ↗
43. 10.3389/fcell.2023.121445010.3389/fcell.2023.1214450 ↗
44. 10.1016/j.ejpb.2019.12.01410.1016/j.ejpb.2019.12.014 ↗
45. 10.1007/s11064-021-03488-710.1007/s11064-021-03488-7 ↗
46. 10.1007/s00415-022-11002-410.1007/s00415-022-11002-4 ↗
47. 10.3200/35-09-00210.3200/35-09-002 ↗
48. 10.1111/bpa.1312410.1111/bpa.13124 ↗
49. 10.3389/fnins.2022.98826510.3389/fnins.2022.988265 ↗
50. 10.1016/j.pneurobio.2009.10.02010.1016/j.pneurobio.2009.10.020 ↗
51. 10.1016/j.tips.2011.06.00110.1016/j.tips.2011.06.001 ↗
52. 10.1016/j.ajhg.2016.01.01410.1016/j.ajhg.2016.01.014 ↗
53. 10.1038/sj.cdd.440229110.1038/sj.cdd.4402291 ↗
54. 10.1016/S1474-4422(09)70062-610.1016/S1474-4422(09)70062-6 ↗
55. 10.1016/S1353-8020(11)70065-710.1016/S1353-8020(11)70065-7 ↗
56. Kempuraj D. · J. Neurol. Neurosurg. Spine. · 2016 · 1 · 1003
57. 10.1002/ana.1072810.1002/ana.10728 ↗
58. 10.1097/NEN.0b013e31818e5e9910.1097/NEN.0b013e31818e5e99 ↗
59. 10.1016/j.brainresbull.2022.11.00510.1016/j.brainresbull.2022.11.005 ↗
60. 10.1186/1742-2094-9-19710.1186/1742-2094-9-197 ↗
61. 10.1371/journal.pone.025577810.1371/journal.pone.0255778 ↗
62. 10.1016/S1474-4422(12)70190-410.1016/S1474-4422(12)70190-4 ↗
63. 10.1093/hmg/ddw18510.1093/hmg/ddw185 ↗
64. 10.1074/jbc.M30912720010.1074/jbc.M309127200 ↗
65. 10.1038/s41531-021-00206-610.1038/s41531-021-00206-6 ↗
66. 10.1038/nature1324110.1038/nature13241 ↗
67. 10.1007/s00702-003-0007-910.1007/s00702-003-0007-9 ↗
68. 10.1002/path.564010.1002/path.5640 ↗
69. 10.7150/thno.6921710.7150/thno.69217 ↗
70. 10.1093/jnci/djv32610.1093/jnci/djv326 ↗
71. 10.3390/biom1102027110.3390/biom11020271 ↗
72. 10.2147/CMAR.S19920710.2147/CMAR.S199207 ↗
73. 10.3390/biom1101002510.3390/biom11010025 ↗
74. 10.1016/j.ijpharm.2014.05.04410.1016/j.ijpharm.2014.05.044 ↗
75. 10.1016/j.xphs.2020.03.03010.1016/j.xphs.2020.03.030 ↗
76. 10.14806/ej.17.1.20010.14806/ej.17.1.200 ↗
77. 10.1038/nmeth.331710.1038/nmeth.3317 ↗
78. 10.1038/nbt.312210.1038/nbt.3122 ↗
79. 10.1186/s13059-014-0550-810.1186/s13059-014-0550-8 ↗
80. 10.1093/bioinformatics/btp61610.1093/bioinformatics/btp616 ↗
81. 10.1016/j.cmet.2020.06.01610.1016/j.cmet.2020.06.016 ↗
82. 10.1038/s42255-021-00425-410.1038/s42255-021-00425-4 ↗